With an off-label drug discontinued, families' other option costs thousands more

Babies who need hormone-inducing drugs to prevent premature puberty have lost an off-label option. The pharmaceutical company, which costs 1/8 the price of the FDA-approved version, withdrew it.

Leave a Comment

Your email address will not be published. Required fields are marked *